| Literature DB >> 32030688 |
Abstract
Sphingosine-1-phosphate (S1P), together with other phosphosphingolipids, has been found to regulate complex cellular function in the tumor microenvironment (TME) where it acts as a signaling molecule that participates in cell-cell communication. S1P, through intracellular and extracellular signaling, was found to promote tumor growth, angiogenesis, chemoresistance, and metastasis; it also regulates anticancer immune response, modulates inflammation, and promotes angiogenesis. Interestingly, cancer cells are capable of releasing S1P and thus modifying the behavior of the TME components in a way that contributes to tumor growth and progression. Therefore, S1P is considered an important therapeutic target, and several anticancer therapies targeting S1P signaling are being developed and tested in clinics.Entities:
Keywords: Cancer metastasis; Cell motility; Chemotaxis; Hypoxia-inducible factor 1α (HIF1α); Immunomodulation; Inflammation; Macrophage polarization; Nuclear factor-κB (NF-κB); Sphingosine kinase (SphK); Sphingosine-1 phosphate (S1P); Sphingosine-1 phosphate receptors (S1PR); TAM/M2 macrophages; Tumor angiogenesis; Tumor growth; Tumor microenvironment
Mesh:
Substances:
Year: 2020 PMID: 32030688 DOI: 10.1007/978-3-030-35582-1_7
Source DB: PubMed Journal: Adv Exp Med Biol ISSN: 0065-2598 Impact factor: 2.622